Showing results (91-100 of 197) with videos related to
Sort By:
Pageof 20
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 14, 2020
The GABA<sub>B</sub> receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivativesFrancesca Ferlenghi, Paola Maccioni, Claudia Mugnaini, et al.Chemmedchem|August 8, 2006
Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ringGiorgio Tarzia, Andrea Duranti, Giuseppe Gatti, et al.Chemmedchem|July 2, 2021
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic StabilityFrancesca Ferlenghi, Michele Mari, Gabriella Gobbi, et al.The Journal of Pharmacy and Pharmacology|October 4, 2019
Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in ratsValentina Vozella, Faizy Ahmed, Paoula Choobchian, et al.Chemistry & Biodiversity|December 29, 2006
Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitorsMarco Mor, Silvia Rivara, Alessio Lodola, et al.Biochemical Pharmacology|February 15, 2023
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approachFrancesca Romana Ferrari, Carmine Giorgio, Alfonso Zappia, et al.CNS Drug Reviews|July 13, 2006
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)Daniele Piomelli, Giorgio Tarzia, Andrea Duranti, et al.European Journal of Medicinal Chemistry|January 7, 2012
Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chainFabrizio Bordi, Silvia Rivara, Elisa Dallaturca, et al.Journal of Medicinal Chemistry|December 8, 2006
Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligandsAnnalida Bedini, Gilberto Spadoni, Giuseppe Gatti, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2013
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitorsFederica Vacondio, Caterina Carmi, Elena Galvani, et al.Pageof 20